All In Biotech

Drug Trial Radar · NCT07235046

A Study of DII235 in Adults With Elevated Lipoprotein(a)

A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate Efficacy, Safety, and Tolerability of DII235 in Adults With Elevated Lipoprotein(a)

Last checked: Nov 19, 2026Latest source record: Aug 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 234 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

234

Actual

Start

Dec 2, 2025

Primary completion

Apr 26, 2027

Study completion Apr 25, 2028

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Nov 19, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).

Conditions

  • Lipoprotein Disorder

Interventions

  • DII235Drug

    Solution for injection

  • SalineDrug

    solution for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time averaged percentage change from baseline between Day 60 and Day 180Time frame: baseline to day 60 and day 180
  2. Difference between DII235 dose 2 and placebo in time-averaged percent change from baseline in Lp(a) measured between Day 60 and Day 360Time frame: baseline to day 60 and day 360
  3. Difference between DII235 dose 4 and placebo in time-averaged percent change from baseline in Lp(a) measured between Day 60 and Day 360Time frame: baseline to day 60 and day 360

Locations

63 sites in 4 countries. Site status is shown where the registry gives one.

  • Parkway Medical Center

    Birmingham, Alabama

  • Heart Center Research Llc

    Huntsville, Alabama

  • Cardiology and Medicine Clinic PA

    Little Rock, Arkansas

  • National Heart Institute

    Beverly Hills, California

  • Alliance Clinical

    Canoga Park, California

  • Excel Medical Clinical Trials LLC

    Boca Raton, Florida

  • Zenith Clinical Research

    Hollywood, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Flourish Res Acq LLC North Miami

    Miami, Florida

  • Inpatient Research Clinical LLC

    Miami Lakes, Florida

  • Ocala Cardiovascular Research

    Ocala, Florida

  • SEC Clinical Research

    Pensacola, Florida

  • Cardiology Partners Clinical Research Institute

    Wellington, Florida

  • Atlanta Heart Specialists LLC

    Tucker, Georgia

  • AMR Chicago

    Niles, Illinois

  • CV Ins of the South

    Lafayette, Louisiana

  • Monroe Research Llc

    West Monroe, Louisiana

  • Metropolitan Cardiovascular Consultants Llc

    Beltsville, Maryland

  • Anderson Medical Research

    Ft. Washington, Maryland

  • Capitol Cardiology Associates

    Lanham, Maryland

  • AA Medical Research Center

    Flint, Michigan

  • Trinity Health Michigan Heart

    Ypsilanti, Michigan

  • Cardiology Associates of North MS

    Tupelo, Mississippi

  • AB Clinical Trials

    Las Vegas, Nevada

  • K and R Research LLC

    Marion, Ohio

  • TCV Clinical Studies

    Linwood, Pennsylvania

  • Cardiology Consultants of Philadelphia

    Yardley, Pennsylvania

  • Apex Cardiology Research Associates of Jackson

    Jackson, Tennessee

  • Alliance for Multispecialty Research

    Knoxville, Tennessee

  • Angiocardiac Care of Texas PA

    Houston, Texas

  • Dallas Heart and Vascular Consultants PA

    Houston, Texas

  • Biopharma Informatic

    Katy, Texas

  • Clinical Trials of Texas

    San Antonio, Texas

  • Northwest Houston Clinical Research PLLC

    Tomball, Texas

  • Progressive Clinical Research

    Bountiful, Utah

  • Dominion Medical Associates

    Richmond, Virginia

  • MultiCare Ins Research Innovation

    Puyallup, Washington

  • Novartis Investigative Site

    Beijing, China

  • Novartis Investigative Site

    Luoyang, Henan, China

  • Novartis Investigative Site

    Shenyang, Liaoning, China

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.